@pld89 I wouldn’t read into what they said they might further disclose a completion of the potency work that the company had flagged at the annual results CC would take a few months. It’s more in terms of clarifying what they would be or had started working on. That was the nature of my question to the company as I tried to assess their confidence in delivering the work to satisfy the FDA’s further data request.
I would re-read @dachopper ‘s very comprehensive first post on 6 Sep on the chronology of work completed since 2020 to get a better understanding of what they might now be doing. Doing an advanced search for MSB under his authorship will take you there.
Cell Therapy News/Articles, page-16951
-
- There are more pages in this discussion • 870 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |